Alfaro, Rosalie D.
HRN: 01-08-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2024
CEFTRIAXONE 1G (VIAL)
09/10/2024
09/17/2024
IV
1g
Q12
Spondylosis Disk Dessication L4- L5
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes